0.035742
0.000000
0.000000
0.000000
0.033281
0.000000
0.000000
0.000000
0.018563
0.00000
0.00000
0.00000
0000-0002-0247-9495
Rhys, G.G.
0000-0003-1243-3105
Wood, C.W.
0000-0003-2203-0027
Beesley, J.L.
0000-0002-3575-5513
Brady, R.L.
0000-0002-0394-3202
Woolfson, D.N.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
27.978
30.047
53.871
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C6 H13 N O4 S
195.237
2-(N-MORPHOLINO)-ETHANESULFONIC ACID
non-polymer
H2 N
16.023
AMINO GROUP
non-polymer
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
US
J.Am.Chem.Soc.
JACSAT
1520-5126
141
8787
8797
10.1021/jacs.8b13354
31066556
Navigating the Structural Landscape of De Novo alpha-Helical Bundles.
2019
0000-0002-0247-9495
0000-0003-1243-3105
0000-0003-2203-0027
0000-0002-1476-2044
0000-0002-1066-1369
0000-0002-0394-3202
80
1
N
PIXEL
2018-05-19
DECTRIS PILATUS 6M-F
SINGLE WAVELENGTH
M
x-ray
1
0.9795
1.0
I04
Diamond
0.9795
SYNCHROTRON
DIAMOND BEAMLINE I04
3259.860
CC-Hex*-L24H
2
syn
polymer
195.237
2-(N-MORPHOLINO)-ETHANESULFONIC ACID
1
syn
non-polymer
18.015
water
28
nat
water
no
yes
(ACE)GELKAIAQELKAIAKELKAIAWEHKAIAQG(NH2)
XGELKAIAQELKAIAKELKAIAWEHKAIAQGX
B,A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
1.74
29.17
VAPOR DIFFUSION, SITTING DROP
6.5
0.8 M sodium citrate
293
citation
citation_author
pdbx_database_proc
repository
Initial release
Data collection
Database references
1
0
2019-05-22
1
1
2019-06-19
_citation.journal_volume
_citation.page_first
_citation.page_last
_citation.title
_citation_author.identifier_ORCID
_citation_author.name
United Kingdom
Biotechnology and Biological Sciences Research Council
BB/J014400/1
United Kingdom
Engineering and Physical Sciences Research Council
EP/G036764/1
Belgium
European Research Council
340764
United Kingdom
Biotechnology and Biological Sciences Research Council
BB/R00661X/1
United Kingdom
Engineering and Physical Sciences Research Council
EP/K03927X/1
N
PDBE
Y
PDBE
2018-12-09
REL
REL
MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID
HOH
water
32630
synthetic construct
sample
1
32
MES
1
2
MES
MES
101
B
HOH
15
3
HOH
HOH
201
B
HOH
7
3
HOH
HOH
202
B
HOH
25
3
HOH
HOH
203
B
HOH
10
3
HOH
HOH
204
B
HOH
9
3
HOH
HOH
205
B
HOH
1
3
HOH
HOH
206
B
HOH
4
3
HOH
HOH
207
B
HOH
5
3
HOH
HOH
208
B
HOH
18
3
HOH
HOH
209
B
HOH
12
3
HOH
HOH
210
B
HOH
21
3
HOH
HOH
211
B
HOH
16
3
HOH
HOH
212
B
HOH
17
3
HOH
HOH
213
B
HOH
27
3
HOH
HOH
101
A
HOH
8
3
HOH
HOH
102
A
HOH
26
3
HOH
HOH
103
A
HOH
13
3
HOH
HOH
104
A
HOH
2
3
HOH
HOH
105
A
HOH
28
3
HOH
HOH
106
A
HOH
23
3
HOH
HOH
107
A
HOH
11
3
HOH
HOH
108
A
HOH
22
3
HOH
HOH
109
A
HOH
20
3
HOH
HOH
110
A
HOH
14
3
HOH
HOH
111
A
HOH
3
3
HOH
HOH
112
A
HOH
24
3
HOH
HOH
113
A
HOH
6
3
HOH
HOH
114
A
HOH
29
3
HOH
HOH
115
A
ACE
0
n
1
ACE
0
B
GLY
1
n
2
GLY
1
B
GLU
2
n
3
GLU
2
B
LEU
3
n
4
LEU
3
B
LYS
4
n
5
LYS
4
B
ALA
5
n
6
ALA
5
B
ILE
6
n
7
ILE
6
B
ALA
7
n
8
ALA
7
B
GLN
8
n
9
GLN
8
B
GLU
9
n
10
GLU
9
B
LEU
10
n
11
LEU
10
B
LYS
11
n
12
LYS
11
B
ALA
12
n
13
ALA
12
B
ILE
13
n
14
ILE
13
B
ALA
14
n
15
ALA
14
B
LYS
15
n
16
LYS
15
B
GLU
16
n
17
GLU
16
B
LEU
17
n
18
LEU
17
B
LYS
18
n
19
LYS
18
B
ALA
19
n
20
ALA
19
B
ILE
20
n
21
ILE
20
B
ALA
21
n
22
ALA
21
B
TRP
22
n
23
TRP
22
B
GLU
23
n
24
GLU
23
B
HIS
24
n
25
HIS
24
B
LYS
25
n
26
LYS
25
B
ALA
26
n
27
ALA
26
B
n
28
27
B
n
29
28
B
n
30
29
B
n
31
30
B
n
32
31
B
ACE
0
n
1
ACE
0
A
GLY
1
n
2
GLY
1
A
GLU
2
n
3
GLU
2
A
LEU
3
n
4
LEU
3
A
LYS
4
n
5
LYS
4
A
ALA
5
n
6
ALA
5
A
ILE
6
n
7
ILE
6
A
ALA
7
n
8
ALA
7
A
GLN
8
n
9
GLN
8
A
GLU
9
n
10
GLU
9
A
LEU
10
n
11
LEU
10
A
LYS
11
n
12
LYS
11
A
ALA
12
n
13
ALA
12
A
ILE
13
n
14
ILE
13
A
ALA
14
n
15
ALA
14
A
LYS
15
n
16
LYS
15
A
GLU
16
n
17
GLU
16
A
LEU
17
n
18
LEU
17
A
LYS
18
n
19
LYS
18
A
ALA
19
n
20
ALA
19
A
ILE
20
n
21
ILE
20
A
ALA
21
n
22
ALA
21
A
TRP
22
n
23
TRP
22
A
GLU
23
n
24
GLU
23
A
HIS
24
n
25
HIS
24
A
n
26
25
A
n
27
26
A
n
28
27
A
n
29
28
A
n
30
29
A
n
31
30
A
n
32
31
A
1.5855
0.3720
2.0894
2.6954
0.3307
9.7632
0.0873
0.0706
0.1675
-0.2051
-0.1713
-0.1719
-0.1865
0.0748
0.0840
0.0464
0.0202
0.0314
0.0220
0.0204
0.0413
refined
3.1630
5.9680
18.3090
X-RAY DIFFRACTION
0.9850
-0.1450
-0.2244
1.6972
-1.1125
9.2622
0.0033
0.0916
0.1079
-0.2653
-0.0974
-0.2558
-0.0113
0.2788
0.0941
0.0585
0.0247
0.0418
0.0429
0.0241
0.0469
refined
6.6700
0.3230
12.2540
X-RAY DIFFRACTION
B
0
B
25
X-RAY DIFFRACTION
1
A
1
A
24
X-RAY DIFFRACTION
2
author_and_software_defined_assembly
PISA
4
tetrameric
equilibrium centrifugation
5170
-50
6430
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
2_555
-x,-y,z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
1
B
CA
ALA
26
A
CA
ALA
27
1
Y
1
B
C
ALA
26
A
C
ALA
27
1
Y
1
B
O
ALA
26
A
O
ALA
27
1
Y
1
B
CB
ALA
26
A
CB
ALA
27
1
Y
1
A
C
HIS
24
B
C
HIS
25
1
Y
1
A
O
HIS
24
B
O
HIS
25
1
Y
1
A
CB
HIS
24
B
CB
HIS
25
1
Y
1
A
CG
HIS
24
B
CG
HIS
25
1
Y
1
A
ND1
HIS
24
B
ND1
HIS
25
1
Y
1
A
CD2
HIS
24
B
CD2
HIS
25
1
Y
1
A
CE1
HIS
24
B
CE1
HIS
25
1
Y
1
A
NE2
HIS
24
B
NE2
HIS
25
1
Y
1
B
ILE
27
A
ILE
28
1
Y
1
B
ALA
28
A
ALA
29
1
Y
1
B
GLN
29
A
GLN
30
1
Y
1
B
GLY
30
A
GLY
31
1
Y
1
B
NH2
31
A
NH2
32
1
Y
1
A
LYS
25
B
LYS
26
1
Y
1
A
ALA
26
B
ALA
27
1
Y
1
A
ILE
27
B
ILE
28
1
Y
1
A
ALA
28
B
ALA
29
1
Y
1
A
GLN
29
B
GLN
30
1
Y
1
A
GLY
30
B
GLY
31
1
Y
1
A
NH2
31
B
NH2
32
1
Y
1
B
LYS
25
-38.98
-36.58
29.959
0.49
0.00
0.00
-1.69
0.00
1.20
0.959
0.934
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
0.24689
0.21067
0.21235
1.41
26.95
411
8356
4.7
95.00
3.427
0.060
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.078
0.082
0.80
0.80
1.00
1.41
26.95
28
422
12
0
382
0.009
0.013
409
0.001
0.017
428
1.479
1.624
547
1.486
1.586
996
3.008
5.000
49
32.106
24.375
16
14.773
15.000
84
0.076
0.200
53
0.008
0.020
433
0.003
0.020
67
3.562
1.882
202
3.556
1.881
202
4.847
2.772
251
4.844
2.780
252
7.312
2.766
207
5.933
2.706
205
10.827
3.917
297
9.802
25.590
477
9.826
25.783
478
1
B
1
619
X-RAY DIFFRACTION
interatomic distance
0.11
0.05
2
A
1
619
X-RAY DIFFRACTION
interatomic distance
0.11
0.05
0.386
0.402
1.447
22
430
20
69.22
1.41
27.96
6Q5L
8784
0.998
0.088
0.037
0.092
0.86
1
11.0
9.7
95.2
0.857
1.41
1.45
1.0
452
0.492
0.665
1.008
0.39
1
3.5
70.9
0.104
6.31
27.96
23.0
136
0.997
0.044
0.110
1.18
1
9.1
98.7
refinement
REFMAC
5.8.0232
data reduction
DIALS
1.9.3-gb491019a
data scaling
Aimless
0.6.2
phasing
PHASER
2.8.2
N
CC-Hex-L24H
Crystal structure of a CC-Hex mutant that forms an antiparallel four-helix coiled coil CC-Hex*-L24H
1
N
N
1
N
N
2
N
N
3
N
N
3
N
N
B
GLY
1
A
GLY
2
HELX_P
B
LYS
25
A
LYS
26
1
AA1
25
A
GLY
1
B
GLY
2
HELX_P
A
HIS
24
B
HIS
25
1
AA2
24
covale
1.342
both
B
ACE
0
A
C
ACE
1
1_555
B
GLY
1
A
N
GLY
2
1_555
covale
1.326
both
A
ACE
0
B
C
ACE
1
1_555
A
GLY
1
B
N
GLY
2
1_555
DE NOVO PROTEIN
coiled coil, tetramer, synthetic, antiparallel, cc-hex, DE NOVO PROTEIN
B
A
B
1
B
23
0
A
1
A
23
0
6Q5L
PDB
1
1
6Q5L
0
31
6Q5L
0
31
6Q5L
B
1
1
32
0
31
6Q5L
0
31
6Q5L
A
1
1
32
binding site for residue MES B 101
B
MES
101
Software
4
binding site for Di-peptide ACE A 0 and GLY A 1
A
ACE
0
Software
8
A
HOH
106
E
HOH
4
1_556
B
GLU
9
A
GLU
10
4
4_556
B
LYS
25
A
LYS
26
4
1_555
B
ALA
26
A
ALA
27
4
1_555
A
GLU
2
B
GLU
3
8
1_555
A
LEU
3
B
LEU
4
8
1_555
A
LYS
4
B
LYS
5
8
1_555
A
ALA
5
B
ALA
6
8
1_555
A
HOH
101
E
HOH
8
1_555
B
LYS
15
A
LYS
16
8
3_546
B
ALA
19
A
ALA
20
8
3_546
B
ALA
21
A
ALA
22
8
1_555
18
P 21 21 2